Yale Medical School Got Caught Defying the Supreme Court. For Three Years.
On May 14, 2026 — nearly three years after the Supreme Court ruled race-based admissions unconstitutional — the Department of Justice delivered a Letter of Findings to Yale University School of Medicine concluding that Yale had continued discriminating against Asian and white applicants across three consecutive admissions cycles (2023, 2024, and 2025). The letter, signed by Harmeet K. Dhillon (R), Assistant Attorney General for Civil Rights, cites Title VI of the Civil Rights Act of 1964 and documents what it calls an internal paper trail showing Yale’s leadership actively sought to circumvent the SFFA v. Harvard ruling rather than comply with it.
The findings are stark. DOJ investigators documented a 29-to-1 odds disparityat the interview-invitation stage: an equally credentialed Black applicant was up to 29 times more likely to receive an interview invitation than an Asian applicant. Internal slide decks recovered during the investigation — titled “Admissions post-SCOTUS” and “Race-Neutral Admissions: Examples from Literature” — showed Yale administrators studying how to use essay prompts and holistic review criteria as proxies to reproduce the same racial preferences the Court had just outlawed.
What makes this case particularly damning is the history: AG Merrick Garland (D) dropped the Trump DOJ’s 2020 suit against Yale without prejudice in February 2021, handing the university a five-year reprieve during which, DOJ now says, the discrimination continued and deepened. Yale has $450 million or more in annual NIH grants at risk under Title VI. No federal funding freeze has been issued yet; DOJ is seeking a voluntary consent agreement first, with litigation reserved as the next step.
- 29×odds disparityfor equally credentialed Asian vs. Black applicants at the interview-invitation stage— DOJ Letter of Findings, May 14, 2026
- 3consecutive admissions cyclesof documented post-SCOTUS discrimination (2023, 2024, 2025)— DOJ
- $450M+annual NIH grantsat risk under Title VI if DOJ moves to funding enforcement— NIH Research Portfolio
- 2021year Garland dropped the prior suitgiving Yale a five-year reprieve — the Biden DOJ walked away without a consent decree— NPR, Feb. 3, 2021
The DOJ investigation reviewed three full admissions cycles: academic years 2023, 2024, and 2025. That timeline matters. The Supreme Court decided Students for Fair Admissions v. Harvard on June 29, 2023. Yale had nearly three years and three full admissions rounds in which to comply. DOJ says it did not.
Investigators found that Yale’s Medical School Admissions Committee used race as a determinative factor at multiple decision points: screening for interview invitations, final offer decisions, and waitlist management. The odds disparity at the interview screening stage — the earliest filtering step — was the most extreme. At that gate, according to the DOJ Letter of Findings, a Black applicant with equivalent academic credentials had up to 29 times higher odds of receiving an invitation than an Asian applicant.
Asian/white admitted applicants (median): GPA 3.97–3.98 · MCAT 100th percentile
Black admitted applicants (median): GPA 3.88 · MCAT 95th percentile
These figures appear in the DOJ Letter of Findings as evidence that race was operating as a thumb on the scale beyond any holistic or credential-neutral explanation. The finding does not contest the competence of admitted Black applicants; it contests whether race was the operative factor that differentiated outcomes between groups with overlapping credential ranges.
The internal documents are the sharpest element of the letter. DOJ obtained two presentations circulated within Yale’s admissions apparatus after SFFA was decided: “Admissions post-SCOTUS” and “Race-Neutral Admissions: Examples from Literature.” DOJ characterizes these not as compliance documents but as roadmaps for evasion — cataloging techniques for using essay prompts, “lived experience” scoring, and socioeconomic proxies in ways designed to reproduce racial preferences while maintaining plausible deniability about race-consciousness.
“Yale has continued its race-based admissions program despite the Supreme Court and the public's clear mandate for reform.”
Harmeet K. Dhillon (R, Trump appointee) · Assistant Attorney General, DOJ Civil Rights Division · Letter of Findings, May 14, 2026
This is not the first time the federal government investigated Yale for race discrimination in admissions. The Trump DOJ opened an investigation in 2018, filed a civil complaint in August 2020, and found what it called “race and national origin as a factor in virtually every admissions decision” in Yale’s undergraduate college. That case never went to trial.
On February 3, 2021— two weeks after Biden’s inauguration — AG Merrick Garland (D) dismissed the complaint without prejudice. Without a consent decree, without a monitoring agreement, without any enforceable change to Yale’s admissions practices. Yale’s statement at the time called the dismissal “the right outcome.” DOJ issued no public findings. The case simply closed.
From February 2021 (Garland dismissal) to June 2023 (SFFA ruling): Yale ran two more admissions cycles under no federal oversight or consent agreement.
From June 2023 (SFFA) to May 2026 (DOJ letter): Yale ran three more admissions cycles — the three that DOJ has now found to be in violation of Title VI.
Total: five admissions cycles(2021–2025) during which there was no active federal enforcement, no consent decree, and no court order governing Yale Medical School’s race-use practices. The DOJ’s 2026 letter covers the last three. What happened in the first two remains unexamined in the public record.
AG William Tong (D-CT) has not issued a statement on the DOJ findings as of publication. Sen. Chris Murphy (D-CT) and Sen. Richard Blumenthal (D-CT) have not issued statements defending Yale’s admissions practices or disputing DOJ’s evidence, as of publication.
Law professor and legal analyst Jonathan Turley has written that the internal Yale presentations represent what DEI administrators were planning from the moment SFFA came down: a systematic attempt to use essays and holistic criteria as “an indirect way to achieve the same identifications and preferences” that explicit race-based admissions had achieved. Turley’s analysis of the DOJ’s findings characterizes the slide decks as evidence not of good-faith compliance planning but of deliberate circumvention.
The internal Yale documents show DEI administrators were preparing to use essays as an indirect way to achieve the same identifications and preferences that the Supreme Court had just ruled unconstitutional. That is not compliance. That is evasion with extra steps.
The “Race-Neutral Admissions: Examples from Literature” presentation is particularly significant. It was prepared for what DOJ describes as a Yale admissions committee retreat — suggesting the workaround strategy was not the rogue act of a single administrator but an institutionally coordinated policy discussion at a senior level. Yale’s President Maurie McInnis (first woman to lead the university, since July 2024) and Dean Nancy J. Brown, MD of the Yale School of Medicine have been named as institutional leadership. Neither has been accused of personal wrongdoing; the investigation targets institutional conduct.
Yale is not an isolated target. DOJ issued a nearly identical Letter of Findings to the UCLA David Geffen School of Medicine around May 6–7, 2026 — roughly one week before the Yale letter. The two letters together signal a deliberate enforcement campaign by the Dhillon-led Civil Rights Division: identify elite medical schools that continued race-conscious admissions post-SFFA, build the evidentiary record during the investigation phase, then issue findings and seek consent agreements — with litigation as the next step if schools refuse.
Yale University President: Maurie McInnis (no party affiliation; first woman president, since July 2024)
Dean, Yale School of Medicine: Nancy J. Brown, MD (no party affiliation)
DOJ Civil Rights Division AAG (signed the letter): Harmeet K. Dhillon (R, Trump appointee)
Biden AG who dropped the 2021 suit: Merrick Garland (D)
Connecticut AG: William Tong (D-CT)
Connecticut Senators: Chris Murphy (D-CT) · Richard Blumenthal (D-CT)
Yale issued a public statement in response to the DOJ findings. It did not dispute the specific statistical findings. It did not address the internal slide decks. It offered no commitment to change its admissions process before the next cycle begins.
“The students admitted to Yale School of Medicine demonstrate exceptional academic achievement and personal commitment... We will carefully review the Department of Justice's letter.”
Yale University official statement · May 2026
“Carefully review” is institutional language for we are buying time. Yale’s lawyers are almost certainly examining whether to negotiate a consent decree, litigate, or attempt a procedural delay. The DOJ letter sets out that the department “reserves the right to initiate legal proceedings” if a voluntary resolution is not reached. Given that Yale has $450 million or more in NIH grants — all of which flow through federal contracts subject to Title VI conditions — the financial exposure is real.
Today, @CivilRights told Yale that its use of race in admissions is ILLEGAL — and that @TheJusticeDept will step in to enforce Title VI. The Supreme Court was clear. Yale chose not to listen. That ends now.
President Trump's January 2025 executive orders directed all federal agencies to eliminate DEI-based discrimination at institutions receiving federal funding. The Yale DOJ enforcement action is a direct product of those orders — the Civil Rights Division executing the policy mandate the President set on Day One.
Paraphrased commentary · not a verbatim post
Elite universities like Yale have spent years pretending to comply with the Supreme Court while engineering the same discriminatory outcomes through back doors. Equal treatment under the law is not negotiable. The DOJ is right to act.
Paraphrased commentary · not a verbatim post
Sen. Tom Cotton (R-AR) has been a consistent critic of DEI admissions practices at elite universities.
The DOJ Letter of Findings is not a lawsuit. It is the step before one. Under Title VI enforcement protocol, the sequence works like this:
Step 1 (complete): DOJ investigation and Letter of Findings — informs Yale of the specific violations identified.
Step 2 (current): Voluntary compliance phase — DOJ seeks a consent agreement committing Yale to specific measurable changes to its admissions process, with monitoring and reporting requirements. No funding freeze yet.
Step 3 (reserved):If Yale refuses or negotiations fail, DOJ may file a civil lawsuit under Title VI. At that stage, the department could also initiate referral to the Department of Education to suspend or terminate Yale’s federal funding — including NIH grants — while litigation proceeds.
Funding at risk: Yale School of Medicine receives an estimated $450 million or more in annual NIH grants. That figure does not include other federal contracts and education grants across the broader university. A Title VI funding suspension would be the largest enforcement action of its kind against a medical school in American history.
Yale’s likely play is to negotiate a narrow consent decree that requires formal procedural changes — removing explicit race tags from applicant files, restructuring the criteria reviewers use at the interview-invitation stage — while preserving as much admissions committee discretion as possible. Whether DOJ accepts a procedural fix or demands outcome-based monitoring is the central negotiating question.
The DOJ has already demonstrated, with the UCLA letter, that it is running a coordinated campaign rather than reacting to individual complaints. Other elite medical schools — particularly those that released public statements after SFFApledging continued “holistic” review without significant process changes — should treat the Yale and UCLA letters as a preview of their own investigation horizon.
The Supreme Court spoke in June 2023. Yale Medical School spent three admissions cycles building slide decks on how not to listen. The DOJ has now documented the 29-to-1 disparity, the internal evasion playbook, and the credential gaps that resulted. Merrick Garland gave Yale five years of breathing room by walking away in 2021 without a consent decree. That runway is over. Yale can negotiate or litigate. Either way, $450 million in NIH grants is now on the table — and the Dhillon Civil Rights Division has made clear it is not done with elite medical schools.